Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | ¥36,943 | ¥29,965 | ¥15,391 | ¥16,065 |
| - Cash | ¥2,149 | ¥2,207 | ¥2,379 | ¥3,241 |
| + Debt | ¥11,938 | ¥11,885 | ¥10,493 | ¥11,318 |
| Enterprise Value | ¥46,732 | ¥39,643 | ¥23,505 | ¥24,142 |
| Revenue | ¥13,011 | ¥14,034 | ¥12,025 | ¥11,906 |
| % Growth | -7.3% | 16.7% | 1% | – |
| Gross Profit | ¥2,558 | ¥2,262 | ¥1,997 | ¥2,129 |
| % Margin | 19.7% | 16.1% | 16.6% | 17.9% |
| EBITDA | ¥2,083 | ¥1,697 | ¥1,668 | ¥1,674 |
| % Margin | 16% | 12.1% | 13.9% | 14.1% |
| Net Income | ¥696 | ¥691 | ¥309 | ¥291 |
| % Margin | 5.3% | 4.9% | 2.6% | 2.4% |
| EPS Diluted | 23.21 | 22.71 | 20.33 | 18.96 |
| % Growth | 2.2% | 11.7% | 7.2% | – |
| Operating Cash Flow | ¥0 | ¥0 | ¥0 | ¥920 |
| Capital Expenditures | ¥0 | ¥0 | ¥0 | -¥2,444 |
| Free Cash Flow | ¥0 | ¥0 | ¥0 | -¥1,524 |